title: For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
abstract: The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).
authors.affiliation: Department of Global Health and Amsterdam Institute for Global Health and Development, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. f.cobelens@aighd.org
authors.forename: Frank G J
authors.initials: FG
authors.lastname: Cobelens
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*; D018088:Tuberculosis, Multidrug-Resistant
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid